KLRS

NASDAQ · Equity

Kalaris Therapeutics, Inc.

US Healthcare Biotechnology

Latest week
29 May 2026
Close
5.270000
Fair value
19.822758
Expectation
Negative 39.79%
Weekly Close Trend Line Fair Value Activity Lines

Chart Summary

Key Points

Week Ending
29 May 2026
Latest Close
5.27
12-Week Change
-39.22%
Trend Signal
Inactive
Expectation
Negative 39.79%
Signal Weeks
3 of 12
Vs Trend Line
Below
Vs Fair Value
Below
Relative Strength
-24.91
Market Dynamics
-0.96

Over the latest 12 completed weeks ending 2026-05-29, KLRS fell 39.22%, moving from 8.67 to 5.27. The latest weekly close is below the Trend Line and below Fair Value. Trend Signal is inactive on the latest week and was active in 3 of the last 12 weeks. Relative Strength is -24.91 and has softened across the 12-week window. Market Dynamics is -0.96 on the latest week. Expectation is negative at 39.79%.